Long-Acting β-Agonist/Inhaled Corticosteroid in Patients with Chronic Obstructive Pulmonary Disease with Cardiovascular Disease or Risk: A Factorial Analysis of the SUMMIT Clinical Trial. uri icon

Overview

publication date

  • June 15, 2018

Research

keywords

  • Adrenal Cortex Hormones
  • Adrenergic beta-2 Receptor Agonists
  • Bronchodilator Agents
  • Cardiovascular Diseases
  • Pulmonary Disease, Chronic Obstructive

Identity

Scopus Document Identifier

  • 85049048705

Digital Object Identifier (DOI)

  • 10.1164/rccm.201710-2052LE

PubMed ID

  • 29412688

Additional Document Info

volume

  • 197

issue

  • 12